Referenced-EEG Has 65 Percent “Success” Rates on Treatment-Resistant Depression
CNS Response today announced that physicians using Referenced-EEG (rEEG(R)) had “success” rates reaching 65 percent for patients with treatment-resistant depression. Referenced-EEG showed “significant improvement” in informing pharmacotherapy for treatment-resistant patients in a 12-week study, according to the Journal of Psychiatric Research article.
- UCI to study novel method to treat pain, depression
- FDA nod to Neuronetics’ Neurostar TMS system
- Genentech submits sBLA for Avastin’s use in glioblastoma treatment
- Rituxan fails to meet primary endpoint in Phase II/III study for PMS
